Potential of George Medicines’ novel, low-dose, triple
NewsletterReceive the most important news of the day by email
London, UK 24 September 2024 – George Medicines, a late-stage,
biopharmaceutical company addressing significant unmet need in the
treatment...
1 week ago
from: GlobeNewswire